Oliver Bandmann

385a Glossop Road
Sheffield, ENG S102HQ, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Variable mitochondrial phenotypes and reduced complex IV assembly factor SCO2 in LRRK2-G2019S fibroblasts.

Variable mitochondrial phenotypes and reduced complex IV assembly factor SCO2 in LRRK2-G2019S fibroblasts.

Journal: Scientific reports

Published: March 05, 2026

Neuroprotection in Parkinson Disease.

Neuroprotection in Parkinson Disease.

Journal: Neurology and therapy

Published: April 28, 2025

Loneliness, social isolation, and effects on cognitive decline in patients with dementia: A retrospective cohort study using natural language processing.

Loneliness, social isolation, and effects on cognitive decline in patients with dementia: A retrospective cohort study using natural language processing.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: February 06, 2025

Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.

Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: December 06, 2024

A zebrafish model of acmsd deficiency does not support a prominent role for ACMSD in Parkinson's disease.

A zebrafish model of acmsd deficiency does not support a prominent role for ACMSD in Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: November 09, 2024

Clinical Trial Highlights: Modulators of Mitochondrial Function.

Clinical Trial Highlights: Modulators of Mitochondrial Function.

Journal: Journal of Parkinson's disease

Published: September 11, 2023

Polygenic Risk Scores Validated in Patient-Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease.

Polygenic Risk Scores Validated in Patient-Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease.

Journal: Annals of neurology

Published: June 08, 2023

Multimodal assessment of mitochondrial function in Parkinson's disease.

Multimodal assessment of mitochondrial function in Parkinson's disease.

Journal: Brain : a journal of neurology

Published: April 02, 2023

A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.

A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 15, 2023

3α,7-Dihydroxy-14(13→12)abeo-5β,12α(H),13β(H)-cholan-24-oic Acids Display Neuroprotective Properties in Common Forms of Parkinson's Disease.

3α,7-Dihydroxy-14(13→12)abeo-5β,12α(H),13β(H)-cholan-24-oic Acids Display Neuroprotective Properties in Common Forms of Parkinson's Disease.

Journal: Biomolecules

Published: December 04, 2022

Increased fracture risk in Parkinson's disease - An exploration of mechanisms and consequences for fracture prediction with FRAX.

Increased fracture risk in Parkinson's disease - An exploration of mechanisms and consequences for fracture prediction with FRAX.

Journal: Bone

Published: October 27, 2022

Unexpected phenotypic and molecular changes of combined glucocerebrosidase and acid sphingomyelinase deficiency.

Unexpected phenotypic and molecular changes of combined glucocerebrosidase and acid sphingomyelinase deficiency.

Journal: Disease models & mechanisms

Published: October 23, 2022

Showing 1-12 of 75

Last Updated: 09/26/2026